Figure 1–
a) Widespread maculopapular rash. b) Chest computed tomography showing bilateral micronodular lesions with ground-glass and non-specific consolidations and linear opacities (mainly in the lower lobes). c) Results of drug-patch testing at day 2 for Malarone® (GlaxoSmithLkine, Research Triangle Park, NC, USA), atovaquone, proguanil, mefloquine, chloroquine and quinine.